RELATIONSHIP BETWEEN EXPRESSION OF SYNOVIAL B CELL SURVIVAL FACTORS AND CLINICAL RESPONSE TO RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Thurlings, R. [1 ]
Boumans, M. [1 ]
de Jager, W. [2 ]
Vos, K. [1 ,3 ]
van Baarsen, L. [1 ]
Gerlag, D. [1 ]
Prakken, B. [2 ]
Tak, P. P. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Flevoziekenhuis, Almere, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5312
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0140
引用
收藏
页码：850 / 850
页数：1
相关论文
共 50 条
  • [31] Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    Breedveld, Ferdinand
    Agarwal, Sunil
    Yin, Ming
    Ren, Song
    Li, Nicole F.
    Shaw, Tim M.
    Davies, Brian E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1119 - 1128
  • [32] BLOOD B CELL COUNTS AS PREDICTOR OF EARLY CLINICAL RESPONSE AFTER RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kim, Y. J.
    Koo, B. S.
    So, M. -W.
    Seo, W. J.
    Kim, Y. -G.
    Lee, C. -K.
    Yoo, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 890 - 890
  • [33] Understanding the relationship between the synovial fibroblast and the mesenchymal stem cell in rheumatoid arthritis
    Basmaeil, Yasser
    Augello, Andrea
    De Bari, Cosimo
    [J]. SCOTTISH MEDICAL JOURNAL, 2015, 60 (03) : E27 - E28
  • [34] Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis
    Vos, Koen
    Thurlings, Rogier M.
    Wijbrandts, Carla A.
    van Schaardenburg, Dirkjan
    Gerlag, Danielle M.
    Tak, Paul P.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (03): : 772 - 778
  • [35] Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis
    Vos, K.
    Thurlings, R. M.
    Wijbrandts, C. A.
    van Schaardenburg, D.
    Gerlag, D. M.
    Tak, P. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A9 - A10
  • [36] Relationship Between the Type I Interferon Signature and the Response to Rituximab in Rheumatoid Arthritis Patients
    Thurlings, Rogier M.
    Boumans, Marie
    Tekstra, Janneke
    van Roon, Joel A.
    Vos, Koen
    van Westing, Daisy Marie
    van Baarsen, Lisa G.
    Bos, Carina
    Kirou, Kyriakos A.
    Gerlag, Danielle M.
    Crow, Mary K.
    Bijlsma, Johannes W.
    Verweij, Cornelis L.
    Tak, Paul P.
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (12): : 3607 - 3614
  • [37] A PARADOXICAL RELATIONSHIP BETWEEN BAFF AND B CELLS REVEALED BY RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS
    El-Sherbiny, Yasser
    Ponchel, Frederique
    Rawstron, Andrew C.
    Emery, Paul
    Vital, Edward M.
    [J]. RHEUMATOLOGY, 2015, 54 : 81 - 81
  • [38] Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis
    Dass, Shouvik
    Vital, Edward M.
    Emery, Paul
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (18) : 2559 - 2570
  • [39] DISRUPTION OF DOMINANT B-CELL/PLASMA CELL CLONES IN RHEUMATOID ARTHRITIS SYNOVIUM BY RITUXIMAB CORRELATES WITH TREATMENT RESPONSE
    Doorenspleet, M. E.
    Klarenbeek, P. L.
    Boumans, M. J.
    Thurlings, R. M.
    Esveldt, R. E.
    van Schaik, B. D.
    van Kampen, A. H.
    Gerlag, D. M.
    Baas, F.
    Tak, P. P.
    Plenge, R. M.
    de Vries, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 313 - 313
  • [40] Disruption of Dominant B-Cell and Plasma Cell Clones in Rheumatoid Arthritis Synovium by Rituximab Correlates with Treatment Response
    Doorenspleet, Marieke E.
    Klarenbeek, Paul L.
    Boumans, Maartje J.
    Thurlings, Rogier M.
    Esveldt, Rebecca E.
    van Schaik, Barbera D.
    van Kampen, Antoine H.
    Gerlag, Danielle M.
    Baas, Frank
    Tak, Paul-Peter
    Plenge, Robert M.
    de Vries, Niek
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S751 - S751
12345